Synovus Financial Corp Royalty Pharma PLC Transaction History

Synovus Financial Corp

$9.33 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Synovus Financial Corp holds 104,297 shares of RPRX stock, worth $2.68 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

104,297

Previous 222,676 53.16%

Holding current value

$2.68 Million

Previous $5.87 Million 49.75%

% of portfolio

0.03%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $3.03 Million - $3.46 Million	-118,379 Reduced 53.16%	104,297 $2.95 Million
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $2.94 Million - $3.35 Million	111,918 Added 101.05%	222,676 $5.87 Million
Q1 2024 May 14, 2024	SELL	$27.46 - $31.33 $246,673 - $281,437	-8,983 Reduced 7.5%	110,758 $3.36 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $649,173 - $775,744	24,721 Added 26.02%	119,741 $3.25 Million
Q2 2023 Aug 08, 2023	SELL	$29.6 - $36.56 $122,810 - $151,687	-4,149 Reduced 4.18%	95,020 $2.92 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $202,321 - $243,255	6,174 Added 6.64%	99,169 $3.57 Million
Q4 2022 Feb 06, 2023	BUY	$39.17 - $44.04 $61,340 - $68,966	1,566 Added 1.71%	92,995 $3.68 Million
Q3 2022 Oct 27, 2022	BUY	$39.88 - $44.65 $68,473 - $76,664	1,717 Added 1.91%	91,429 $3.68 Million
Q2 2022 Aug 10, 2022	BUY	$37.53 - $44.22 $325,122 - $383,077	8,663 Added 10.69%	89,712 $3.77 Million
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $104,925 - $118,874	-2,801 Reduced 3.34%	81,049 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $2.95 Million - $3.56 Million	83,850 New	83,850 $3.34 Million

Others Institutions Holding RPRX

# of Institutions

412

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Royalty Pharma PLC Transaction History